// App-Quantinova.ai

TCT-432 : IMPACT OF GENDER ON 1-YEAR OUTCOMES AFTER IMPLANTATION OF BIORESORBABLE DRUG-ELUTING SCAFFOLDS

Researchers

Presenter

  • Moritz Baquet

Principal Investigators

  • Diona Gjermeni

  • Modena Bajraktari

  • David Jochheim

  • Dominic Dischl

  • Dirk Sibbing

  • Giuseppe Tarantini

  • Steffen Massberg

  • Julinda Mehilli

Medical Centers

  • University of Munich, Munich, Germany

  • Munich University Clinic, Munich, Germany

  • Klinikum der Universitat, Ludwig Maximilians Universitat, Munich, Germany

  • Hospital of Munich, Germany

  • PADUA HOSPITAL, PADUA, Italy

  • Ludwig Maximilians University Munich, Munich, Germany

  • University of Munich, Munich, Germany

Locations

  • Germany

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Coronary Artery Disease

  • Myocardial infarction

  • Venous thrombosis

  • Restenosis

  • Diabetes

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved